glp 1 agonist meds GLP-1 receptor agonists Unlocking the broad health benefits
Description
May have higher risk of GI or metabolic side effects
Brand names: Ozempic (diabetes), Wegovy (obesity)
However, doses of 120mg twice daily were shown to be more associated with the production of reduced appetite, dyspepsia and dizziness
The success of tirzepatide has validated the multi-agonist approach, driving substantial research and development in this area
Clinical Trial Results SURMOUNT-1 trial: Average weight loss of ~20% of total body weight
[1] Dulaglutide (Trulicity): 0.75 mg or 1.5 mg once weekly for type 2 diabetes
